Jean-Claude "JC" Kyrillos is the Vice President and General Manager for Qualcomm Life. In this role, he has responsibility for the company's worldwide operating units and driving operational excellence across the company.
JC has 30 years of diversified business experience, including 13 years of executive leadership in the medical device industry in acute care, homecare, and diagnostics. Prior to joining Qualcomm Life, JC was the worldwide vice president and general manager of BD’s (Becton, Dickinson and Company) global Infusion Solutions business (previously CareFusion). In this role, he led BD’s Alaris® infusion pump systems, including embedded and enterprise software with over $1 billion in annual revenues and ~5,000 global employees. Infusion pump systems are medical devices used to infuse drugs, fluids, and nutrition – predominantly for intravenous (IV) indications. Before BD/CareFusion, JC was president, ResMed Ventures and Initiatives and previously Co-Leader for ResMed, Americas. ResMed is a medical device company focused on sleep-disordered breathing, including obstructive sleep apnea. JC was the 16th employee and later Chief Operating Officer of GeneOhm Sciences a venture capital backed molecular diagnostics company focusing on rapid response diagnostic tests for infectious disease. GeneOhm was purchased by BD in 2006. Earlier in his career JC held several positions at Honeywell International, including finance leader for a ~$500 mil in annual revenues electronic materials business where he was based for three years in Hong Kong. JC serves on the Board of Directors for the San Diego Blood Bank and the Sharp Healthcare Foundation. He earned a MBA from Harvard Business School and a BA with Honors in History from Colgate University.